Lucid Diagnostics Inc expected to post a loss of 38 cents a share - Earnings Preview

Lucid Diagnostics

10/03/2023 14:06

* Lucid Diagnostics Inc  LUCD.OQ   LUCD.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 14. 
    * The New York City-based  company is expected to report  a
14.6% increase in revenue to $343.8 thousand from $300 thousand
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lucid Diagnostics
Inc is
for a loss of 38 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lucid
Diagnostics
Inc is $4.5​, above​ its last closing price of $1.65. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.42       -0.40      -0.39     Beat    1.7
 Jun. 30 2022  -0.36       -0.36      -0.41     Missed  -14.2
 Mar. 31 2022  -0.35       -0.33      -0.35     Missed  -5.3​
 Dec. 31 2021  -0.20       -0.20      -0.32     Missed  -58
 ​​Sep.        -0.32       -0.32      -0.49     Missed  -54.7
 30 2021                                                
                                                        ​
 This summary was machine generated March 10 at 14:06 GMT.  All
figures in US dollars  unless otherwise stated